{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:43:45Z","timestamp":1789681425713,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ekir.2019.12.001","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T13:10:10Z","timestamp":1576156210000},"page":"435-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome"],"prefix":"10.1016","volume":"5","author":[{"given":"Raymond","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Batten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-5512","authenticated-orcid":false,"given":"Bobby","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2019.12.001_bib1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2019.12.001_bib2","doi-asserted-by":"crossref","first-page":"A506","DOI":"10.1016\/j.chest.2016.02.528","article-title":"Undiagnosed and unsuspected nephrotic syndrome in a young adult presenting as submassive pulmonary embolism","volume":"149","author":"Khanna","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ekir.2019.12.001_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/20009666.2018.1562854","article-title":"The forgotten urinalysis: an integral part of unmasking thrombophilia","volume":"9","author":"Qureshi","year":"2019","journal-title":"J\u00a0Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.ekir.2019.12.001_bib4","doi-asserted-by":"crossref","first-page":"e950","DOI":"10.1097\/MJT.0000000000000075","article-title":"Stroke in a young woman as a presenting manifestation of membranous nephropathy","volume":"23","author":"Pallavi","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.ekir.2019.12.001_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9343(78)90848-3","article-title":"Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome","volume":"65","author":"Kauffmann","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.ekir.2019.12.001_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ki.1994.274","article-title":"Thrombosis and hemostasis in renal disease","volume":"46","author":"Rabelink","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2019.12.001_bib7","first-page":"218","article-title":"Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria","volume":"106","author":"Cosio","year":"1985","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.ekir.2019.12.001_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.1982.tb03862.x","article-title":"Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome","volume":"52","author":"Jackson","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ekir.2019.12.001_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJM197402212900805","article-title":"Platelet function in hyperlipoproteinemia","volume":"290","author":"Carvalho","year":"1974","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2019.12.001_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000187205","article-title":"Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted?","volume":"63","author":"Bellomo","year":"1993","journal-title":"Nephron"},{"key":"10.1016\/j.ekir.2019.12.001_bib11","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2006111300","article-title":"Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum","volume":"18","author":"Glassock","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/rth2.12101","article-title":"Current and future burden of venous thrombosis: not simply predictable","volume":"2","author":"Scheres","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.ekir.2019.12.001_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.amjmed.2007.08.042","article-title":"Venous thromboembolism in patients hospitalized with nephrotic syndrome","volume":"121","author":"Kayali","year":"2008","journal-title":"Am J Med"},{"issue":"23 suppl 1","key":"10.1016\/j.ekir.2019.12.001_bib14","first-page":"I4","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2019.12.001_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-2006-951293","article-title":"Epidemiology and risk factors of venous thromboembolism","volume":"32","author":"Ageno","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ekir.2019.12.001_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000448628","article-title":"Venous thromboembolism in primary nephrotic syndrome\u2013is the risk high enough to justify prophylactic anticoagulation?","volume":"135","author":"Rankin","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.ekir.2019.12.001_bib17","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2019.12.001_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ki.2011.312","article-title":"Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis","volume":"81","author":"Barbour","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2019.12.001_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12882-018-0999-x","article-title":"Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes","volume":"19","author":"Fenton","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/ndt\/gfw227","article-title":"Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome","volume":"32","author":"Gyamlani","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2019.12.001_bib21","first-page":"555","article-title":"Histological diagnosis and risk of renal vein thrombosis, and other thrombotic complications in primitive nephrotic syndrome","volume":"54","author":"Harza","year":"2013","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.ekir.2019.12.001_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2369-13-107","article-title":"Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study","volume":"13","author":"Kumar","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.thromres.2012.04.015","article-title":"Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome\u2013a prospective study","volume":"130","author":"Li","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.ekir.2019.12.001_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10157-015-1149-4","article-title":"Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome","volume":"20","author":"Li","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2215\/CJN.04250511","article-title":"Venous thromboembolism in patients with membranous nephropathy","volume":"7","author":"Lionaki","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.ajkd.2016.10.032","article-title":"The clinical course of minimal change nephrotic syndrome with onset in adulthood or late adolescence: a case series","volume":"69","author":"Maas","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2019.12.001_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: clinical characteristics, treatment, and outcomes","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1148\/radiol.14140121","article-title":"Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT","volume":"273","author":"Zhang","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.ekir.2019.12.001_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.24920\/11809","article-title":"A\u00a0cohort study of incidences and risk factors for thromboembolic events in patients with idiopathic membranous nephropathy","volume":"33","author":"Zou","year":"2018","journal-title":"Chin Med Sci J"},{"key":"10.1016\/j.ekir.2019.12.001_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12882-019-1336-8","article-title":"Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications","volume":"20","author":"Kelddal","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2215\/CJN.07190713","article-title":"Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000188355","article-title":"Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparin","volume":"69","author":"Rostoker","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.ekir.2019.12.001_bib33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000319925","article-title":"Low-molecular-weight heparin successfully used to treat a nephrotic patient complicated by superior mesenteric vein thrombosis and portal vein thrombosis","volume":"20","author":"Wang","year":"2011","journal-title":"Med Princip Pract"},{"key":"10.1016\/j.ekir.2019.12.001_bib34","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/ndt\/17.11.2017","article-title":"The successful treatment of renal-vein thrombosis by low-molecular-weight heparin in a steroid-sensitive nephrotic patient","volume":"17","author":"Yang","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2019.12.001_bib35","doi-asserted-by":"crossref","first-page":"983A","DOI":"10.1378\/chest.2280343","article-title":"Failure of anticoagulation in a case of nephrotic syndrome with recurrent thromboembolism","volume":"148","author":"Basu","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.ekir.2019.12.001_bib36","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1177\/1060028014549349","article-title":"Use of rivaroxaban in a patient with history of nephrotic syndrome and hypercoagulability","volume":"48","author":"Dupree","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"suppl 3","key":"10.1016\/j.ekir.2019.12.001_bib37","first-page":"64","article-title":"Warfarin vs new oral anticoagulant in primary adult nephrotic syndrome associated venous thormboembolism","volume":"22","author":"Han","year":"2017","journal-title":"Nephrology"},{"key":"10.1016\/j.ekir.2019.12.001_bib38","article-title":"Poor response to rivaroxaban in nephrotic syndrome with acute deep vein thrombosis: a case report","volume":"98","author":"Li","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.ekir.2019.12.001_bib39","first-page":"669","article-title":"Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapy","volume":"32","author":"Reynolds","year":"2019","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000362162","article-title":"Carotid thromboembolism associated with nephrotic syndrome treated with dabigatran","volume":"4","author":"Sasaki","year":"2014","journal-title":"Case Rep Nephrol Urol"},{"key":"10.1016\/j.ekir.2019.12.001_bib41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ekir.2018.02.010","article-title":"Direct-acting oral anticoagulants as prophylaxis against thromboembolism in the nephrotic syndrome","volume":"3","author":"Sexton","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2019.12.001_bib42","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.2169\/internalmedicine.8742-16","article-title":"Edoxaban was effective for treating renal vein thrombosis in a patient with nephrotic syndrome","volume":"56","author":"Shimada","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.ekir.2019.12.001_bib43","first-page":"739","article-title":"Rivaroxaban for the treatment of venous thromboembolism in patients with nephrotic syndrome and low AT-III: a pilot study","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ekir.2019.12.001_bib44","doi-asserted-by":"crossref","first-page":"iii109","DOI":"10.1093\/ndt\/gfv171.15","article-title":"Is the risk of venous thromboembolism overstated in primary nephrotic syndrome?","volume":"3","author":"Rankin","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2019.12.001_bib45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.thromres.2015.06.031","article-title":"Mechanisms of hypercoagulability in nephrotic syndrome associated with membranous nephropathy as assessed by thromboelastography","volume":"136","author":"Huang","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.ekir.2019.12.001_bib46","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1160\/TH05-08-0565","article-title":"Renal vein thrombosis and membranous glomerulopathy in a patient homozygote for factor V Leiden mutation: a mere coincidence?","volume":"95","author":"Elinav","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ekir.2019.12.001_bib47","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5414\/CN107863","article-title":"Assessment of genetic risk factors for thromboembolic complications in adults with idiopathic nephrotic syndrome","volume":"79","author":"Sahin","year":"2013","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib48","first-page":"1034","article-title":"[Incidence and clinical significance of thromboses and thrombo-embolic complications in nephrotic syndrome patients]","volume":"111","author":"Kuhlmann","year":"1981","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.ekir.2019.12.001_bib49","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11255-013-0574-0","article-title":"Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters","volume":"46","author":"Ismail","year":"2014","journal-title":"Int. Urol. Nephrol"},{"key":"10.1016\/j.ekir.2019.12.001_bib50","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ki.2013.476","article-title":"Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy","volume":"85","author":"Lee","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2019.12.001_bib51","author":"Nachman"},{"key":"10.1016\/j.ekir.2019.12.001_bib52","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ekir.2019.12.001_bib53","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","volume":"60","author":"Apostolakis","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2019.12.001_bib54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacc.2012.10.010","article-title":"Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients","volume":"61","author":"Apostolakis","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2019.12.001_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1378\/chest.12-0608","article-title":"Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a \"real-world\" population with atrial fibrillation receiving anticoagulant therapy","volume":"143","author":"Roldan","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ekir.2019.12.001_bib56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1183\/09031936.00040714","article-title":"Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review","volume":"45","author":"Klok","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ekir.2019.12.001_bib57","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.amjmed.2015.10.001","article-title":"Evaluation of the HAS-BLED, ATRIA, and ORBIT bleeding risk scores in patients with atrial fibrillation taking warfarin","volume":"129","author":"Senoo","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.ekir.2019.12.001_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2016.04.173","article-title":"Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study","volume":"217","author":"Fauchier","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ekir.2019.12.001_bib59","first-page":"111","article-title":"Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: a prospective cohort study","volume":"22","author":"Kawai","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.ekir.2019.12.001_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/20009666.2018.1466599","article-title":"To be or not to be a case of heparin resistance","volume":"8","author":"Durrani","year":"2018","journal-title":"J\u00a0Community Hospital Intern Med Perspect"},{"issue":"2 suppl","key":"10.1016\/j.ekir.2019.12.001_bib61","doi-asserted-by":"crossref","first-page":"7s","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ekir.2019.12.001_bib62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/2042098613507945","article-title":"Safety of new oral anticoagulant drugs: a perspective","volume":"5","author":"V\u00edlchez","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.ekir.2019.12.001_bib63","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1681\/ASN.2016090980","article-title":"Apixaban pharmacokinetics at steady state in hemodialysis patients","volume":"28","author":"Mavrakanas","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1 suppl","key":"10.1016\/j.ekir.2019.12.001_bib65","doi-asserted-by":"crossref","first-page":"64s","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ekir.2019.12.001_bib66","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-2143(97)90115-3","article-title":"The variable anticoagulant response to unfractionated heparin in\u00a0vivo reflects binding to plasma proteins rather than clearance","volume":"130","author":"Manson","year":"1997","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.ekir.2019.12.001_bib67","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0038-1649639","article-title":"Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (Enoxaparin) to plasma proteins","volume":"70","author":"Young","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ekir.2019.12.001_bib68","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0038-1642434","article-title":"Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin","volume":"71","author":"Young","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ekir.2019.12.001_bib69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11239-015-1315-2","article-title":"Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism","volume":"41","author":"Smythe","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.ekir.2019.12.001_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1472-8206.2011.00981.x","article-title":"Pharmacodynamic and pharmacokinetic basics of rivaroxaban","volume":"26","author":"Kreutz","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ekir.2019.12.001_bib71","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/ndt\/gfy031","article-title":"A\u00a0systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation","volume":"34","author":"Feldberg","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2019.12.001_bib72","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1172\/JCI108035","article-title":"Pharmacokinetics of drugs in patients with the nephrotic syndrome","volume":"55","author":"Gugler","year":"1975","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2019.12.001_bib73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF03189651","article-title":"Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease","volume":"9","author":"Keller","year":"1984","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.ekir.2019.12.001_bib74","first-page":"75","article-title":"Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors","volume":"25","author":"Ganeval","year":"1986","journal-title":"Clin Nephrol"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2019.12.001_bib75","first-page":"142","article-title":"A\u00a0case series of patients treated with escalated doses of doacs","volume":"181","author":"Wharin","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ekir.2019.12.001_bib76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome\u2013associated thromboembolic disease","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024919315700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024919315700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:31:20Z","timestamp":1762831880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024919315700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2468024919315700"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2019.12.001","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2019.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}